Infratil Limited
Infratil Limited (IFUUF) Stock Overview
Explore Infratil Limited’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
5.3B
P/E Ratio
-13.83
EPS (TTM)
$-0.19
ROE
-0.08%
IFUUF Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Infratil Limited (IFUUF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $6.00.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -13.83 and a market capitalization of 5.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.
Company Profile
Infratil Limited owns and operates infrastructure businesses and investments primarily in New Zealand, Australia, the United States, Asia, the United Kingdom, and Europe. The company supplies electricity to commercial and industrial customers; develops, owns, and generates renewable energy; develops utility-scale wind and solar generation throughout North America; develops wind, solar PV energy projects, and storage solutions; and provides outsourced data center services to government and commercial entities, as well as develops and operates data centers. It also owns and manages a portfolio of commercial real estate properties; operates retirement living units and apartments; operates airport; and provides finance services. In addition, the company offers mobile subscription, broadband connection, TV connection services; and diagnostic imaging, a service for various health applications, including x-rays, ultrasound, CT scans, PET scans, and MRIs which are used to prevent, diagnose, and treat a range of diseases and other health issues, such as cardiovascular, musculoskeletal, respiratory, hearing/vision, neurological, kidney, gastrointestinal, and cancer. It owns and operates 27 hydro power stations with a total installed capacity of 498 MW. The company was incorporated in 1994 and is based in Wellington, New Zealand.
Jason Boyes BCA,
7,076
5 Market Lane, Wellington
2018